Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C103303 |
alitretinoin |
alitretinoin results in increased expression of MDK mRNA | increases expression | 14502603
|
C061133 |
Am 80 |
Am 80 results in increased expression of MDK mRNA | increases expression | 17229644
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MDK mRNA | affects expression | 16483693
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of MDK mRNA | decreases expression | 20106945
|
C053541 |
bicalutamide |
bicalutamide results in increased expression of MDK mRNA | increases expression | 15638997
|
D002330 |
Carmustine |
Carmustine results in decreased expression of MDK mRNA | decreases expression | 15980968
|
D002809 |
Chondroitin Sulfates |
Chondroitin Sulfates analog binds to MDK protein | affects binding | 12221095
|
D002809 |
Chondroitin Sulfates |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to MDK protein | affects binding | 15385557
|
D002809 |
Chondroitin Sulfates |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to MDK protein | affects binding | 14699094
|
D003513 |
Cycloheximide |
Cycloheximide promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of MDK mRNA] | decreases expression|increases reaction | 11007951
|
D003871 |
Dermatan Sulfate |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to MDK protein | affects binding | 15385557
|
D003871 |
Dermatan Sulfate |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to MDK protein | affects binding | 14699094
|
D004317 |
Doxorubicin |
MDK mRNA results in decreased susceptibility to Doxorubicin | decreases response to substance | 16322897
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of MDK mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of MDK mRNA | decreases expression | 16174780
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MDK mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of MDK mRNA | decreases expression | 17557909 16174780
|
D015025 |
Zearalenone |
Zearalenone results in decreased expression of MDK mRNA | decreases expression | 19371625
|
D005665 |
Furosemide |
Furosemide results in increased expression of MDK mRNA | increases expression | 16526316
|
C419708 |
gefitinib |
gefitinib inhibits the reaction [TGFA protein results in increased expression of MDK mRNA] | decreases reaction|increases expression | 18424623
|
D019833 |
Genistein |
Genistein results in decreased expression of MDK mRNA | decreases expression | 19371625
|
D006072 |
Gossypol |
Gossypol results in decreased expression of MDK mRNA | decreases expression | 19825521
|
D006072 |
Gossypol |
zoledronic acid promotes the reaction [Gossypol results in decreased expression of MDK mRNA] | decreases expression|increases reaction | 19825521
|
D017313 |
Fenretinide |
Fenretinide results in increased expression of MDK mRNA | increases expression | 16671099
|
D016685 |
Mitomycin |
MDK protein affects the susceptibility to Mitomycin | affects response to substance | 16217747
|
D010100 |
Oxygen |
Oxygen deficiency results in increased expression of MDK mRNA | increases expression | 17914565
|
D010672 |
Phenytoin |
Phenytoin results in increased expression of MDK mRNA | increases expression | 14741686
|
D010795 |
Phthalic Acids |
Phthalic Acids results in increased expression of MDK mRNA | increases expression | 15728792
|
D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in increased expression of MDK mRNA | affects cotreatment|increases expression | 19244175
|
D012643 |
Selenium |
Selenium results in increased expression of MDK mRNA | increases expression | 19244175
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of MDK mRNA | increases expression | 18175754
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of MDK mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
Cycloheximide promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of MDK mRNA] | decreases expression|increases reaction | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of MDK mRNA | decreases expression | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MDK mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of MDK mRNA | increases expression | 17942748
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of MDK mRNA | increases expression | 17138961
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of MDK mRNA | increases expression | 16604517
|
D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in increased expression of MDK mRNA | affects cotreatment|increases expression | 19244175
|
D014810 |
Vitamin E |
Vitamin E results in increased expression of MDK mRNA | increases expression | 19244175
|
C088658 |
zoledronic acid |
zoledronic acid promotes the reaction [Gossypol results in decreased expression of MDK mRNA] | decreases expression|increases reaction | 19825521
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.30 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenytoin |
7.86 | 8986270 9118846 3425630 6195326 9677735 10563481 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.86 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.31 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.69 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
zoledronic acid |
4.24 | 19715164 |
MESH:D055371 |
Acute Lung Injury |
|
Oxygen |
4.31 | 16759491 |
MESH:D000210 |
Acute-Phase Reaction |
|
zoledronic acid |
5.23 | 20200999 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
12.87 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
12.87 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
12.87 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
12.87 | 10697514 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
12.87 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.51 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.13 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.31 | 21441931 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.42 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.73 | 11748828 |
MESH:D000860 |
Anoxia |
|
Oxygen |
4.81 | 20872349 |
MESH:D001008 |
Anxiety Disorders |
marker/mechanism |
|
| 19217924 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.83 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.22 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.71 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.71 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Am 80 |
4.90 | 16819260 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.90 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.27 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Am 80 |
10.56 | 16484594 |
MESH:D050197 |
Atherosclerosis |
|
Oxygen |
10.56 | 16391483 |
MESH:D050197 |
Atherosclerosis |
|
Phenytoin |
10.56 | 15136057 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Phthalic Acids |
4.20 | 20106747 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.17 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.21 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.21 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.54 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.61 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.45 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
zoledronic acid |
4.73 | 16778634 16121404 17312309 11697798 15867366 19442620 |
MESH:D001862 |
Bone Resorption |
|
zoledronic acid |
4.48 | 15845617 18496637 11869084 8053405 18404659 16769263 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
13.62 | 16187019 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
13.62 | 17150277 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
13.62 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
6.75 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
6.75 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
6.75 | 15939500 15692762 16826403 16595493 19526202 15567936 16096432 17426702 15993339 18234424 16264153 17983394 15136595 15668708 18695136 16115903 18628466 18382427 17369602 16935488 15634643 11325840 16322301 15994142 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
6.75 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
6.75 | 16873071 17200150 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Oxygen |
6.75 | 17263869 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
6.75 | 21138602 18351453 19059307 18855134 19289846 19011961 20065188 18629630 16273361 15565566 17242785 19142967 18821012 16202921 20859285 16873071 18997820 20135344 20390343 19189210 17049068 19189212 16818667 15668708 18425577 11161223 20005174 17440819 18984771 19115204 19410462 17893378 17261762 20544844 19103187 19221464 19288272 19084267 19066611 18815881 19244106 19155303 19487384 21152245 19200415 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
6.75 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
6.75 | 16873071 16443354 16166294 |
MESH:D001943 |
Breast Neoplasms |
|
zoledronic acid |
6.75 | 16096432 18695136 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.34 | 16813970 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.69 | 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.56 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.61 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.26 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.91 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
8.45 | 17876044 16234567 16023760 18059187 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
8.45 | 16270382 17159502 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
8.45 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
8.45 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
8.45 | 1917145 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
gefitinib |
6.03 | 20005069 17290066 18347146 19233551 15496427 16230376 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
zoledronic acid |
6.03 | 19233551 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.60 | 1485588 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
zoledronic acid |
6.60 | 18507039 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
10.22 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
10.22 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
10.22 | 16274795 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
10.22 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.40 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.23 | 16120746 18670907 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.37 | 15811867 17351982 17382496 17308081 16278810 17519947 16952015 16109756 17131338 16731534 15792986 16269455 17329180 15476868 17007740 16364871 16455267 17924179 16242529 15505089 16612575 16651473 17928571 17974986 18627295 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.86 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.14 | 16332659 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.95 | 17460283 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenytoin |
5.06 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
12.15 | 16154183 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
12.15 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.96 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.70 | 17110522 17681005 15861022 16919318 11677210 16105132 17333356 |
OMIM:601042 |
CHOREOATHETOSIS/SPASTICITY, EPISODIC |
|
Phenytoin |
5.62 | 11748493 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.91 | 16461808 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.51 | 15894690 |
MESH:D002971 |
Cleft Lip |
|
Phenytoin |
4.03 | 2227380 |
MESH:D002972 |
Cleft Palate |
|
Phenytoin |
9.32 | 1687470 6862529 6856622 10789828 2227380 3877104 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
9.32 | 15340226 15668235 8697196 12621046 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
9.32 | 9407595 |
MESH:D003092 |
Colitis |
|
Selenium |
8.69 | 17936198 |
MESH:D003092 |
Colitis |
|
Tretinoin |
8.69 | 17035595 |
MESH:D003103 |
Coloboma |
|
Phenytoin |
4.93 | 9212184 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
2.25 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.63 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
3.63 | 17273769 |
MESH:D015179 |
Colorectal Neoplasms |
|
gefitinib |
3.63 | 17594712 |
MESH:D000013 |
Congenital Abnormalities |
|
Phenytoin |
8.70 | 10627286 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
8.70 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Phenytoin |
5.21 | 19952982 9212184 8986270 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.21 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
5.21 | 9211117 16925845 8800419 17551590 9224671 10589399 9142499 14991402 9125849 9664655 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
5.21 | 19769572 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.12 | 19031437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.57 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.12 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.12 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.27 | 19279558 |
OMIM:607208 |
DRAVET SYNDROME |
|
Phenytoin |
5.15 | 11748493 |
MESH:D003875 |
Drug Eruptions |
|
Phenytoin |
5.26 | 15024534 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
8.38 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
8.38 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
8.38 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.38 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.51 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.51 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Furosemide |
9.97 | 16935035 |
MESH:D004417 |
Dyspnea |
|
Oxygen |
9.97 | 20016425 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.45 | 9068938 |
MESH:D004487 |
Edema |
|
Furosemide |
6.38 | 11834646 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.38 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.11 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.11 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Am 80 |
20.09 | 16819260 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
20.09 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Phenytoin |
20.09 | 17654737 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
20.09 | 19031437 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.34 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
16.50 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
16.50 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
16.50 | 16202921 19155303 20544844 17893378 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
16.50 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.81 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.91 | 18037988 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Phenytoin |
4.96 | 20235791 |
MESH:D004820 |
Epidermolysis Bullosa |
|
Phenytoin |
5.98 | 1399206 6251365 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenytoin |
4.67 | 11558140 17116037 |
MESH:D004827 |
Epilepsy |
|
Phenytoin |
3.81 | 20417680 11434505 821787 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenytoin |
5.06 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenytoin |
4.82 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
1.95 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.24 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.24 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
6.96 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
6.96 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.09 | 16709447 |
MESH:D005264 |
Femoral Fractures |
|
zoledronic acid |
5.58 | 16234978 |
MESH:D005313 |
Fetal Death |
|
Phenytoin |
9.93 | 10627286 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
9.93 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.28 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
10.62 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
10.62 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.82 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
7.82 | 17994277 |
MESH:D005739 |
Gas Poisoning |
|
Oxygen |
4.97 | 20016425 |
MESH:D005885 |
Gingival Hyperplasia |
|
Phenytoin |
5.42 | 9029455 |
MESH:D019214 |
Gingival Overgrowth |
|
Phenytoin |
5.98 | 14659971 16390469 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
20.59 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
20.59 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
20.59 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
20.59 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
20.59 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.34 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.30 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.30 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Furosemide |
4.62 | 17868369 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.91 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
14.90 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
14.90 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
14.90 | 14991402 9664655 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
14.90 | 16080930 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.32 | 17875725 14766674 16244372 16707910 18006777 16144979 16495754 12587719 18674790 16330681 16879835 17888722 16244371 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
11.14 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Furosemide |
11.14 | 16845234 12660669 16011733 |
MESH:D006333 |
Heart Failure |
|
Selenium |
11.14 | 17162251 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.68 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.12 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.65 | 15340226 12621046 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.62 | 16490937 16863852 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.21 | 18501091 15147373 17606976 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
3.72 | 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.80 | 16959395 15340226 16354765 8697196 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.56 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
zoledronic acid |
7.56 | 16769263 |
MESH:D006934 |
Hypercalcemia |
|
Furosemide |
10.56 | 17652376 |
MESH:D006934 |
Hypercalcemia |
|
zoledronic acid |
10.56 | 18089816 19622757 |
MESH:D053565 |
Hypercalciuria |
|
Furosemide |
5.41 | 17652376 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.33 | 16778211 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Phenytoin |
4.46 | 10459572 |
MESH:D006962 |
Hyperparathyroidism, Secondary |
|
Furosemide |
5.63 | 15086907 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.82 | 18850075 18670907 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Furosemide |
5.04 | 16612254 |
MESH:D006976 |
Hypertension, Pulmonary |
|
gefitinib |
4.52 | 18424623 |
MESH:D017380 |
Hypertrophy, Right Ventricular |
|
gefitinib |
5.99 | 18424623 |
MESH:D006996 |
Hypocalcemia |
|
zoledronic acid |
5.94 | 12669777 |
MESH:C537153 |
Hypomagnesemia primary |
|
Furosemide |
5.41 | 11041285 |
MESH:D007019 |
Hypoproteinemia |
|
Furosemide |
5.63 | 16096441 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.57 | 16945680 16569931 |
MESH:D007022 |
Hypotension |
|
Furosemide |
4.39 | 11041285 |
MESH:D007024 |
Hypotension, Orthostatic |
|
Furosemide |
5.17 | 15811171 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.23 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.80 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Gossypol |
6.80 | 11202417 9639145 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
4.47 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.47 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
10.13 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
10.13 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.12 | 14714311 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.53 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.20 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.20 | 15992940 17551590 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.39 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
9.50 | 16775033 15369732 15699352 |
MESH:D007674 |
Kidney Diseases |
|
Furosemide |
9.50 | 11041285 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
9.50 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
9.25 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
9.25 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
gefitinib |
7.31 | 18625569 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
7.31 | 18625569 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.00 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.00 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.91 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
zoledronic acid |
4.55 | 18089816 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.48 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.04 | 16294345 17596541 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Am 80 |
7.63 | 16819260 16531727 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.63 | 19225113 16823087 16140955 16935935 16766008 16891316 17217047 17361223 15748426 19035177 12679006 17649720 16331271 19075265 17506722 16788101 17368321 17301526 19029980 17107899 9834237 17339181 17712046 19642359 17294898 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
5.79 | 16707609 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.13 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.98 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
8.32 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
8.32 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
8.32 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.32 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
8.32 | 16248980 18397230 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
8.32 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Phenytoin |
3.16 | 14986274 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
9.95 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Mitomycin |
9.95 | 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
9.95 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
9.95 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
5.41 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.41 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.01 | 16863852 |
MESH:D055370 |
Lung Injury |
|
Oxygen |
4.27 | 18339021 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
8.14 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
8.14 | 17053015 18816296 20064080 18569708 18520028 6695378 20869020 20464547 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
8.14 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
8.14 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.14 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
8.14 | 11062179 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.29 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
3.83 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.59 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.32 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.51 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
26.12 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
26.12 | 10697514 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
gefitinib |
26.12 | 18375820 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
26.12 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
26.12 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
26.12 | 14580682 16827153 11731420 19196723 19196722 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
zoledronic acid |
26.12 | 17312309 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.30 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.69 | 17453147 |
MESH:D008545 |
Melanoma |
|
Carmustine |
9.33 | 12393984 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
9.33 | 16827129 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
9.33 | 16270382 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
9.33 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
9.33 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.94 | 15990972 |
MESH:D008569 |
Memory Disorders |
marker/mechanism |
|
| 19217924 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.18 | 16940565 |
MESH:D008607 |
Mental Retardation |
|
Phenytoin |
3.59 | 9212184 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
9.76 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
9.76 | 15107826 |
MESH:D008654 |
Mesothelioma |
|
zoledronic acid |
9.76 | 16675582 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.28 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
8.16 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
8.16 | 16274795 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.54 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Am 80 |
7.60 | 17229644 |
MESH:D009101 |
Multiple Myeloma |
|
zoledronic acid |
7.60 | 19621390 18089719 16996129 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
2.94 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.63 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
5.63 | 17141266 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.83 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
3.48 | 17141266 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenytoin |
5.27 | 17484760 |
MESH:D009224 |
Myotonia Congenita |
|
Phenytoin |
5.16 | 1896199 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
9.09 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
9.09 | 19393235 |
MESH:D009362 |
Neoplasm Metastasis |
|
zoledronic acid |
9.09 | 17312309 15867366 19139120 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.44 | 19410462 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
10.94 | 16946489 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
10.94 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
10.94 | 17353921 15958647 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
10.94 | 16594593 16946489 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.75 | 19200415 19189210 19196722 |
MESH:D009397 |
Nephrocalcinosis |
|
Furosemide |
5.63 | 15086907 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.53 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.79 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
15.02 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.02 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
15.02 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Phenytoin |
7.15 | 9118846 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.15 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.14 | 15555623 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.43 | 16303764 |
MESH:D053206 |
Nocturnal Enuresis |
|
Furosemide |
5.63 | 17945291 |
MESH:D010014 |
Osteolysis |
|
zoledronic acid |
5.12 | 15867366 |
MESH:D010018 |
Osteomalacia |
|
Phenytoin |
5.16 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
7.07 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
zoledronic acid |
7.07 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
3.86 | 16169203 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.92 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
7.57 | 16133793 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
7.57 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.57 | 16936753 |
MESH:D010146 |
Pain |
|
Phenytoin |
10.41 | 15215642 |
MESH:D010146 |
Pain |
|
Tretinoin |
10.41 | 16870215 |
MESH:D010146 |
Pain |
|
zoledronic acid |
10.41 | 16475674 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
8.34 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Mitomycin |
8.34 | 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.34 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.46 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.00 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.91 | 17983394 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.64 | 15087411 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.91 | 17638057 |
MESH:D017689 |
Polydactyly |
|
Phenytoin |
4.84 | 9212184 |
MESH:D011141 |
Polyuria |
|
Furosemide |
5.41 | 17945291 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.75 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.32 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.95 | 11896295 11118676 11399792 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Am 80 |
4.13 | 16289102 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
4.13 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bicalutamide |
4.13 | 15638997 17914592 19011039 19240160 18487222 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
4.13 | 15897917 16888761 16868541 15749863 18437689 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
4.13 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
gefitinib |
4.13 | 17914592 15651060 16685379 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
4.13 | 16925846 15256057 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
4.13 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
4.13 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
4.13 | 15084515 |
MESH:D011471 |
Prostatic Neoplasms |
|
zoledronic acid |
4.13 | 19103299 12438248 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.38 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.07 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Phenytoin |
5.29 | 8603615 1419762 12752131 |
MESH:D011565 |
Psoriasis |
|
Am 80 |
4.00 | 16819260 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.55 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
gefitinib |
3.91 | 18424623 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.98 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
Furosemide |
3.79 | 16526316 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Furosemide |
8.95 | 12394941 15912074 16096441 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oxygen |
8.95 | 17627322 18339021 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.60 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
4.22 | 16303925 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.87 | 16283617 16116481 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.78 | 15625365 18313854 17710206 17203757 16767912 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
9.85 | 14601052 16326096 |
MESH:D012512 |
Sarcoma, Ewing's |
|
zoledronic acid |
9.85 | 16121404 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.54 | 17846226 |
MESH:D012640 |
Seizures |
|
Phenytoin |
3.58 | 9844417 15946322 16876388 11044598 3691417 3137016 19919933 10029267 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.38 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
16.70 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
16.70 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
16.70 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
16.70 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
16.70 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.32 | 17203757 16767912 15625365 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.73 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.73 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.79 | 19457130 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Phenytoin |
4.91 | 20235791 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.34 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Furosemide |
3.34 | 17052386 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.34 | 17261132 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.33 | 16517955 |
MESH:D013398 |
Sudden Infant Death |
|
Oxygen |
5.30 | 12563064 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.39 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.95 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.65 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
11.15 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
gefitinib |
11.15 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
11.15 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.57 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.08 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
11.17 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
11.17 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
11.17 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
11.17 | 16712894 8653321 17572228 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
8.99 | 16154183 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
8.99 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.06 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.36 | 16752155 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.34 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.32 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
3.98 | 17638931 17678736 16364871 17334414 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.82 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.00 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.76 | 16287080 |